In-Vitro Activities of Tetracyclines, Macrolides, Fluoroquinolones and Clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years
Clinical Microbiology and Infection, 04/26/2012Krausse R et al.
Ureaplasmas have become more resistant to CIP in 1997–2004, showing high resistance to ERY over the time period (1989–2008). Doxycycline is still the drug of first–choice for ureaplasmal infections and may be used by co–infection with M. hominis. Finally, this study gives recommendation for alternatives in cases of resistance towards the commonly used antimicrobials.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.